Active Ingredient Prescribing Issues Register

The Active ingredient prescribing issues register lists medicines considered for inclusion/exclusion to the List of Medicines for Brand Consideration (LMBC) and the List of Excluded Medicinal Items (LEMI). 

This document was last updated by the Commission in December 2022. From 1 January 2023, the Australian Government Department of Health and Aged Care is managing the curation of Active ingredient prescribing resources. From this date, please direct all AIP enquiries to aiprescribing@health.gov.au

issues register december 2022

Downloads

Active Ingredient Prescribing Issues Register

Download PDF (417.44 KB)

Accessibility - We aim to provide documents in an accessible format. If you're having problems using a document with your accessibility tools, please contact us for help.

Copyright - Unless stated otherwise, materials provided are covered by a Creative Commons Attribution-Non-Commercial-Share Alike (BY-NC-ND) 4.0 International License.

 

Description

The Commission was advised by medication safety experts, who formed the Active ingredient prescribing advisory group (AIPAG). The AIPAG reviewed medicines against the principles for inclusion/exclusion to the LMBC and LEMI, as set out in the Active Ingredient Prescribing User Guide. The recommendations and actions from the AIPAG have been recorded in the Active ingredient prescribing issues register. 

Publication year
2022
Resource type
Publication, report or update